Loading, please wait...Pharmacists and Technicians (Please register for correct option below)
Activity Type
- Knowledge
Target Audience(s)
- Pharmacist
Accreditation(s)
CPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
|
|
|
|
Co-Sponsor(s)
Profero Team
The FDA approves new medications and new indications for existing medications on a continuous basis. Often, these are related to specialty, high cost medications that are complicated by extensive patient monitoring and prior authorizations. A discussion of these new therapeutic updates will improve the ways pharmacists and pharmacy technicians interact with these medications and make clinical decisions in the future.
Objectives
- Identify new therapeutic updates from the FDA or clinical guidelines
- Outline key information from clinical trials or clinical guidelines about these new therapeutic updates
- Describe the effects of new therapeutic updates on Managed Care and Specialty Pharmacy
Speaker(s)/Author(s)
|
Ashley Smith, PharmD
|
Activity Number
0864-9999-22-043-H01-P
Release Date:
Aug 31, 2022
Credit Expiration Date:
Aug 31, 2023
Fee
$10.00
The FDA approves new medications and new indications for existing medications on a continuous basis. Often, these are related to specialty, high cost medications that are complicated by extensive patient monitoring and prior authorizations. A discussion of these new therapeutic updates will improve the ways pharmacists and pharmacy technicians interact with these medications and make clinical decisions in the future.
Objectives
- Identify new therapeutic updates from the FDA or clinical guidelines
- Outline key information from clinical trials or clinical guidelines about these new therapeutic updates
Speaker(s)/Author(s)
|
Ashley Smith, PharmD
|
Activity Number
0864-9999-22-043-H01-T
Release Date:
Aug 31, 2022
Credit Expiration Date:
Aug 31, 2023
Fee
$10.00
